CAS 1143579-78-5

Fórmula: C33H27N5O4

InChI: InChI=1S/C33H27N5O4/c1-37-28-19-29(39)26(33(41)42)18-25(28)31(32(37)23-10-6-3-7-11-23)27-20-38(36-35-27)17-16-30(40)34-24-14-12-22(13-15-24)21-8-4-2-5-9-21/h2-15,18-20,39H,16-17H2,1H3,(H,34,40)(H,41,42)

Chave InChI: RATFAFAWIWHLMR-UHFFFAOYSA-N

SMILES: CN1C2=CC(=C(C=C2C(=C1C3=CC=CC=C3)C4=CN(N=N4)CCC(=O)NC5=CC=C(C=C5)C6=CC=CC=C6)C(=O)O)O

6-Hydroxy-1-methyl-3-[1-[3-oxo-3-(4-phenylanilino)propyl]triazol-4-yl]-2-phenylindole-5-carboxylic acid

CAS: 1143579-78-5

6-Hydroxy-1-methyl-3-[1-[3-oxo-3-(4-phenylanilino)propyl]triazol-4-yl]-2-phenylindole-5-carboxylic acid (Lumefantrine) is a drug that is used to treat HIV. It inhibits the replication of the virus by blocking reverse transcriptase, an enzyme that copies DNA from RNA. Lumefantrine also has antiinflammatory and antiproliferative effects. This drug has been shown to inhibit autophagy and promote apoptosis in cells with HIV infection. Lumefantrine also reduces serum alanine levels, body mass index, and insulin resistance. The drug may have other side effects such as hepatic steatosis, polymerase chain reaction inhibition, and growth factor inhibition.

Fórmula: C₃₃H₂₇N₅O₄

Pureza: Min. 95%

Peso molecular: 557.6 g/mol

Ref: 3D-TVB57978

II-B08

CAS: 1143579-78-5

II-B08 is a cell-permeable SHP2 inhibitor (IC50 = 5.5 µM). II-B08 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation.

Fórmula: C₃₃H₂₇N₅O₄

Cor e Forma: Solid

Peso molecular: 557.6

Ref: TM-T27591